About Bio-Reference Laboratories
Bio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Laboratories & Research
- Sub-Industry: Health Care Services
- Exchange: NASDAQ
- Symbol: BRLI
- CUSIP: 09057G60
Key Metrics:
- Previous Close: $34.61
- 50 Day Moving Average: $41.81
- 200 Day Moving Average: $36.97
- 52-Week Range: $26.32 - $47.49
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 14.98
- P/E Growth: 0.00
- Market Cap: $N/A
Additional Links:
Companies Related to Bio-Reference Laboratories:
Consensus Ratings for Bio-Reference Laboratories (NASDAQ:BRLI) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Bio-Reference Laboratories (NASDAQ:BRLI)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 12/18/2014 | William Blair | Reiterated Rating | Hold | |  |
(Data available from 9/25/2014 forward)
Earnings History for Bio-Reference Laboratories (NASDAQ:BRLI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/25/2015 | | | | | | | | |
| 6/8/2015 | Q215 | $0.44 | $0.38 | $227.33 million | $224.00 million | View | Listen | |
| 3/5/2015 | Q115 | $0.36 | $0.24 | $216.40 million | $209.00 million | View | Listen | |
| 12/18/2014 | Q414 | $0.63 | $0.69 | $228.81 million | $227.60 million | View | Listen | |
| 8/27/2014 | Q314 | $0.53 | $0.55 | $210.44 million | $222.10 million | View | Listen | |
| 6/5/2014 | Q214 | $0.32 | $0.37 | $0.20 million | $201.30 million | View | Listen | |
| 3/4/2014 | Q114 | $0.15 | $0.11 | $175.52 million | $181.30 million | View | Listen | |
| 12/19/2013 | Q4 | $0.55 | $0.40 | $188.96 million | $192.20 million | View | Listen | |
| 8/29/2013 | Q3 2013 | $0.51 | $0.53 | $183.50 million | $185.40 million | View | Listen | |
| 6/6/2013 | Q2 2013 | $0.41 | $0.41 | $176.04 million | $176.50 million | View | Listen | |
| 2/28/2013 | Q1 2013 | $0.28 | $0.31 | $165.44 million | $161.30 million | View | Listen | |
| 12/6/2012 | 0.46 | | $0.46 | | $175.46 million | View | Listen | |
| 8/30/2012 | Q312 | $0.43 | $0.45 | $0.17 million | $0.17 million | View | N/A | |
| 6/7/2012 | | $0.32 | $0.33 | | | View | N/A | |
| 3/1/2012 | | $0.21 | $0.26 | | | View | N/A | |
| 12/8/2011 | | $0.35 | $0.37 | | | View | N/A | |
| 8/25/2011 | | $0.34 | $0.36 | | | View | N/A | |
| 5/26/2011 | | $0.24 | $0.26 | | | View | N/A | |
| 3/3/2011 | | $0.17 | $0.28 | | | View | N/A | |
| 12/16/2010 | | $0.30 | $0.31 | $124.19 million | $126.60 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Bio-Reference Laboratories (NASDAQ:BRLI)Current Year EPS Consensus Estimate: $1.98 EPS
Next Year EPS Consensus Estimate: $2.31 EPS
Dividend History for Bio-Reference Laboratories (NASDAQ:BRLI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Bio-Reference Laboratories (NASDAQ:BRLI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/13/2013 | Howard Dubinett | COO | Sell | 20,000 | $29.40 | $588,000.00 | |
| 6/27/2013 | Sam Singer | CFO | Sell | 4,000 | $28.95 | $115,800.00 | |
| 6/26/2013 | Sam Singer | CFO | Sell | 6,000 | $28.50 | $171,000.00 | |
(Data available from 1/1/2013 forward)
Latest Headlines for Bio-Reference Laboratories (NASDAQ:BRLI)| Date | Headline |
|---|
 | Why Britain's NHS Is Great, Despite Its Dire Financial Situation (NASDAQ:BRLI)
finance.yahoo.com - August 26 at 3:53 PM |
 | Opko Is a Buying Opportunity After FDA's Approval of Kidney Drug (NASDAQ:BRLI)
www.thestreet.com - June 30 at 5:15 PM |
 | Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Updated Price Targets - FTSE News (NASDAQ:BRLI)
www.ftsenews.co.uk - May 27 at 9:50 PM |
 | Next Weeks Broker Price Targets For Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Share Trading News (NASDAQ:BRLI)
www.sharetrading.news - May 23 at 12:51 AM |
| Latest Analyst Ratings For Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Share Trading News (NASDAQ:BRLI)
www.sharetrading.news - May 18 at 9:04 PM |
| Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Latest Broker Views - Risers & Fallers (NASDAQ:BRLI)
www.risersandfallers.com - April 12 at 3:07 AM |
| Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Updated Broker Price Targets - Share Trading News (NASDAQ:BRLI)
www.sharetrading.news - April 9 at 12:28 AM |
| New Analyst Ratings On Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers (NASDAQ:BRLI)
www.risersandfallers.com - April 5 at 9:41 PM |
| Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Updated Broker Ratings - Risers & Fallers (NASDAQ:BRLI)
www.risersandfallers.com - March 31 at 9:28 PM |
| Next Weeks Broker Price Targets For Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers (NASDAQ:BRLI)
www.risersandfallers.com - March 22 at 8:17 PM |
 | How Risky Is Opko Health Inc. Stock? (NASDAQ:BRLI)
www.fool.com - March 18 at 4:19 PM |
| Recent Broker Updates On Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers (NASDAQ:BRLI)
www.risersandfallers.com - March 17 at 10:55 PM |
| Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) New Analyst Ratings - Share Trading News (NASDAQ:BRLI)
www.sharetrading.news - March 15 at 7:52 PM |
| Updated Price Targets On Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers (NASDAQ:BRLI)
www.risersandfallers.com - March 8 at 9:05 PM |
| Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Recent Analyst Updates - Risers & Fallers (NASDAQ:BRLI)
www.risersandfallers.com - February 4 at 10:22 AM |
| Analyst Coverage Updates - Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers (NASDAQ:BRLI)
www.risersandfallers.com - January 27 at 9:55 AM |
| 3 Predictions for Opko Health Inc. in 2016 (NASDAQ:BRLI)
www.fool.com - December 5 at 9:03 AM |
| Opko Health Reports a Surprise Profit -- Were Investors Right to Cheer? (NASDAQ:BRLI)
www.fool.com - November 19 at 7:57 AM |
 | OPKO Health Refinances Bio-Reference Laboratories Credit Facility (NASDAQ:BRLI)
www.noodls.com - November 6 at 11:34 AM |
| Opko Health Has Crashed 55% In Three Months; Time To Buy? (NASDAQ:BRLI)
finance.yahoo.com - September 28 at 10:44 AM |
| Why Insiders Are Buying Opko Health, Inc. Stock (NASDAQ:BRLI)
www.fool.com - September 24 at 10:24 AM |
| OPKO HELATH, INC. Financials (NASDAQ:BRLI)
finance.yahoo.com - August 25 at 1:04 PM |
| Innospec Set to Join the S&P SmallCap 600 (NASDAQ:BRLI)
finance.yahoo.com - August 20 at 6:38 PM |
| BIO REFERENCE LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisit (NASDAQ:BRLI)
biz.yahoo.com - August 20 at 5:05 PM |
| OPKO Completes Acquisition of Bio-Reference Laboratories (NASDAQ:BRLI)
www.noodls.com - August 20 at 11:06 AM |
| BIO REFERENCE LABORATORIES INC Files SEC form 8-K, Other Events (NASDAQ:BRLI)
biz.yahoo.com - August 10 at 5:08 PM |
 | OPKO's Prostate Cancer Hit (NASDAQ:BRLI)
www.forbes.com - July 23 at 8:59 AM |
| OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned Acquisition (NASDAQ:BRLI)
www.noodls.com - July 5 at 1:05 AM |
| Barron's Recap: Airline Stocks Ready To Soar (NASDAQ:BRLI)
finance.yahoo.com - June 21 at 7:13 PM |
| BRLI INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Bio-Reference Laboratories, Inc. Concerning the Sale of the Company to Opko Health Inc. (NASDAQ:BRLI)
finance.yahoo.com - June 16 at 11:44 AM |
Bio-Reference Laboratories (NASDAQ:BRLI) Chart for Sunday, September, 25, 2016
